Despite correlations found previously between TNFα and total body fatness [35] as well as circulating MCP-1 and BMI [36], in our study, increased pro-inflammatory markers and activated pro-inflammatory pathways after MG administration were not associated with any changes in adiposity. Here, CCL2 is linked to myasthenia gravis.